Table 1. Baseline demographic and clinical characteristics.
|
Variable |
All PD participants | PD participants with MRI data |
|---|---|---|
| (N = 423) | (N = 160) | |
| Age | ||
| Mean years (SD; minimum, maximum) | 61.7 (9.7; 33.5, 84.9) | 61.0 (9.6; 38.0, 82.3) |
| Gender | ||
| Male | 277 (65.5%) | 103 (64.4%) |
| Female | 146 (34.5%) | 57 (35.6%) |
| Education | ||
| <13 years | 76 (18.0%) | 38 (23.8%) |
| 13–23 years | 344 (81.3%) | 122 (76.3%) |
| >23 years | 3 (0.7%) | 0 (0.0%) |
| Race | ||
| White | 391 (92.4%) | 151 (94.4%) |
| Black/African-American | 6 (1.4%) | 3 (1.9%) |
| Asian | 8 (1.9%) | 3 (1.9%) |
| Other | 18 (4.3%) | 3 (1.9%) |
| Duration of disease (months) | ||
| Mean (SD; minimum, maximum) | 6.7 (6.5, 0.4, 35.8) | 6.87 (7.0; 0.4, 35.8) |
| MDS-UPDRS Part III score | ||
| Mean (SD; minimum, maximum) | 20.9 (8.9; 4.0, 51.0) | 20.9 (9.1; 4.0, 47.0) |
| GDS score (score ≥5) | 59 (13.9%) | 25 (15.6%) |
| MDS-UPDRS psychosis (score ≥1) | 13 (3.1%) | 6 (3.8%) |